State Supremacy in Decline
- 1 June 1996
- journal article
- Published by Taylor & Francis in Journal of Industry Studies
- Vol. 3 (1) , 87-103
- https://doi.org/10.1080/13662719600000006
Abstract
This paper discusses the dynamics of the international pharmaceutical industry, and how these are creating problems for the Australian government in its efforts to manage change within the regulated domestic industry. The paper argues that regulatory reform and industry development policy have eroded the capacity of the federal government to maintain the pricing regime associated with the Pharmaceutical Benefits Scheme (PBS) since 1950. The bargaining strength of the transnational firms which dominate the pharmaceutical industry in Australia is increasing; current global rationalisation of manufacturing and of R&D make threats to relocate more credible than in the past.Keywords
This publication has 8 references indexed in Scilit:
- Networks of innovators: A synthesis of research issuesPublished by Elsevier ,2002
- The Australian drug regulatory systemAustralian Prescriber, 1995
- National Innovation Systems: Why They Are Important, And How They Might Be Measured And ComparedEconomics of Innovation and New Technology, 1994
- Global R&D networksJournal of Industry Studies, 1993
- National Innovation SystemsPublished by Oxford University Press (OUP) ,1993
- Towards a Schumpeterian Workfare State? Preliminary Remarks on Post-Fordist Political EconomyStudies in Political Economy, 1993
- Institutional relationships and technology commercialization: Limitations of market based policyResearch Policy, 1992
- BiotechnologyPublished by JSTOR ,1986